Search

You searched for "chemoradiotherapy"

176 results found

From the editor March/April 2023

10 March 2023
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTw: @Voicedoctor_uk The world of audiology and ENT will already know of the tragic death of Professor David Baguley in June 2022 at...

4th Annual Inner Ear Disorders Therapeutics Summit

20 August 2024 -22 August 2024
Terrri Gaskell, Chief Technology Officer, Rinri TherapueticsHeld in Boston, USA, this was an essential gathering that captured the growing excitement in both the biotech and clinical communities surrounding the rapid advancements in hearing loss therapies. With the potential to significantly...

The utilisation of three-dimensional printed models in skull base surgery

1 January 2019 | | ENTA-ENT, ENTA-Skull Base Surgery
As technology improves, there are new ways to assist with surgeons when it comes to training and preparing for surgery. Barbara Anne Thomson and Georgios Kontorinis highlight how 3D printing can help with the understanding and surgical planning for complex...

In conversation with Dr John Woo and Mr Derek Skinner

1 March 2017 | | ENTA-ENT, ENTA-Head & Neck
Dr John Woo and Mr Derek Skinner have between them an absolute wealth of experience and expertise in the fields of surgical training and specialist examinations. Here, they tell us about their involvement in surgical education, and explain some of...

Current management of unilateral sporadic vestibular schwannoma

10 March 2023 | | ENTA-Audiology - Adult, ENTA-Skull Base Surgery, ENTA-Vestibular Disorders
Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.

History of innovation in ENT

2 November 2020 | | ENTA-ENT, ENTA-Laryngology / Swallowing / Voice, ENTA-Otology, ENTA-Rhinology / Sinus
Innovation seems to have been in the strapline of every meeting, conference and course for the last few years. You would be forgiven for thinking it is a new a concept, but as Neil Weir beautifully details, innovation has been...

In conversation with Professor Eugene Myers: My life in ENT

1 July 2014 | | ENTA-ENT, ENTA-Head & Neck
In a series of interviews, former Chairman of the Editorial Board for ENT & audiology news, Professor Patrick J Bradley, speaks with eminent otolaryngologists who have retired (or are about to retire) from practice. Our first is with Professor Gene...

Global audiology during COVID-19

26 June 2020 | | ENTA-Audiology - Adult, ENTA-Audiology - Diagnostic, ENTA-Audiology - Paediatric, ENTA-Covid-19
The COVID-19 pandemic has affected, and in some areas, put a complete hold on, audiology practice around the world. In April 2020, during the peak of the pandemic for many regions, our audiology Global Ambassadors provided their reports from their...

Systemic agents in thyroid cancer

1 July 2017 | | ENTA-ENT, ENTA-Head & Neck, ENTA-Thyroid / Parathyroid Surgery
For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...

Have we reached our limits in endoscopic skull base surgery?

1 November 2017 | | ENTA-ENT, ENTA-Head & Neck, ENTA-Skull Base Surgery
As being an anterior skull base surgeon becomes the aspiration of many ENT trainees, Professor Nicolai gives his personal insights into the future for this exciting subspeciality. Having been directly involved in the evolution of transnasal endscopic surgery (TES) since...

Sugammadex

1 November 2019 | | ENTA-ENT
Scott Russell is an anaesthetist with an almost unrivalled experience of complex head and neck surgery, and has seen all manner of new ideas come and go. However, in this article he describes a new pharmaceutical agent that is already...

Head and neck robotic surgery – considerations for the surgical trainee

4 November 2021 | | ENTA-ENT, ENTA-Head & Neck
In 2021, training in head and neck cancer surgery would be incomplete without some robotic resections under the belt. Henry Zhang explains how he did it and outlines the options available. With a wide range of applications in both benign...